The Real Cost of 2.4 mg Wegovy in the UK

The myth that a lower monthly number means the same treatment for less

It's easy to see a lower price and assume you're getting the same thing for less. With Wegovy at 2.4 mg, that assumption is worth examining carefully. Many advertised prices are for the pen alone. They don't include the consultation, the prescription charge, dose-review appointments, or any clinical support between deliveries. When those are added back in, the gap between a cheap-looking listing and a genuinely all-in service often shrinks considerably, or reverses.

That's not a criticism of any specific provider; it's just how fragmented pricing tends to work online. Some services charge separately for each clinical review. Others fold in a subscription you didn't realise you'd agreed to. A few don't appear to include any prescriber oversight at all, which is where things move from inconvenient to genuinely unsafe. Wegovy is licensed for weight management in adults with a BMI of 30 or above, or 27 and above alongside a weight-related condition such as high blood pressure or type 2 diabetes, and reaching the 2.4 mg maintenance dose involves a titration schedule that a prescriber needs to supervise. Understanding how Wegovy works is part of understanding what good clinical oversight looks like.

The gently-held misconception worth letting go is this: that price is the primary variable between weight-loss services. In reality, it's one of the smaller differences. What varies far more is the depth and consistency of clinical review.

What typically drives the cost of 2.4 mg Wegovy in private practice

Wegovy's UK list price rose significantly in late 2025. Eli Lilly's increase for Mounjaro in September of that year prompted wider reporting on GLP-1 pricing across the board, and Novo Nordisk's pricing has followed a comparable trajectory for higher doses. As widely reported, the higher-dose pens of the leading GLP-1 medicines now carry UK list prices that can approach or exceed £300 per four-week pen at the top of the schedule.

For Wegovy specifically, 2.4 mg is the standard maintenance dose reached after a titration period that begins at 0.25 mg, a schedule set out in the medicine's SmPC and described in plain terms on the NHS's semaglutide page. The fact that most patients spend several months on lower doses before reaching 2.4 mg matters for budgeting: the cost at maintenance is not the cost from day one. Providers who quote a single maintenance-dose price without acknowledging the titration journey are giving you an incomplete picture. For a fuller breakdown of how private pricing works across the dose schedule, our Wegovy cost overview sets it out in full.

Legitimate private pricing also reflects the cost of genuine supply through the licensed UK chain. Authorised dispensing pharmacies source from manufacturers' approved distributors; that assurance has a cost, and it's one worth paying. Exploring your weight-loss treatment options can help you weigh those factors in context.

What an all-in price actually needs to include

At nume, we are not the cheapest option, and that is a deliberate position. What the single price you see on our treatment page includes is: the clinical consultation, the same-day review by a GPhC-registered prescriber (a named clinician, not a piece of software), the prescription, the medicine, and free next-working-day tracked delivery via DPD. There are no separate prescription fees, no delivery charges, and no subscription locking you into future orders. Every repeat is clinically re-reviewed before dispatch.

For patients considering the 2.4 mg maintenance dose, that means each order is assessed on its own merits. Evidence of tolerability and progress informs each clinical decision. Our prescribers are available for aftercare questions seven days a week. You can read more about our clinical team if you'd like to understand who reviews your consultation. If you have questions before starting, our FAQs cover the most common ones. For anything specific, our support team is reachable directly.

The NICE appraisal of semaglutide (TA875) sets out the clinical rationale for supervised, ongoing weight management support alongside the medicine, a structured service, not just a product.

For a prescription medicine, price is the wrong test

A small saving on a monthly pen is not worth much if the clinical oversight behind it is thin. Counterfeit weight-loss pens are a documented problem in the UK; the MHRA has warned publicly about fake pens sold through unverified online channels, some containing insulin rather than semaglutide. Suspect sellers can be reported at the MHRA's Yellow Card service. The safest step anyone can take is to verify that the pharmacy they're using appears on the GPhC register at pharmacyregulation.org, a check that takes under a minute and confirms you're dealing with a regulated dispensing service.

For those specifically researching what 2.4 mg Wegovy costs per pen, our dedicated pen-price page goes into further detail. If you want to understand how much 2.4 mg Wegovy costs once consultation and dispensing fees are factored in, or if you are still working out how much 2.4 mg Wegovy is across different providers, the right starting point is a free consultation where a prescriber reviews your situation properly. That conversation is where cost, eligibility and clinical fit all come together.